The effect of glucocorticoids on grain dust-induced airway disease

Chest

Volumn 113, Issue 2, 1998, Pages 505-513

  Trapp, John F ^a   Watt, Janet L ^a   Frees, Kathy L ^a   Quinn, Timothy J ^a   Nonnenmann, Matthew W ^a   Schwartz, David A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Airway injury; Asthma; Glucocorticoids; Grain dust

Indexed keywords

ENDOTOXIN; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 8; STEROID; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHOSCOPY; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORN; CROSSOVER PROCEDURE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; GRAIN DUST; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPIROMETRY;

EID: 0031912631     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.2.505     Document Type: Article

References (50)

1. Chan-Yeung M, Enarson DA, Kennedy SM. Impact of grain dust on respiratory health. Am Rev Respir Dis 1992; 145: 476-87
2. Chan-Yeung M, Schulzer M, MacLean L, et al. Epidemiologic health survey of grain elevator workers in British Columbia. Am Rev Respir Dis 1980; 121:329-38
3. doPico G, Reddan W, Anderson S, et al. Acute effects of grain dust exposure during a work shift. Am Rev Respir Dis 1983; 128:399-404
4. Corey P, Hutcheon M, Broder I, et al. Grain elevator workers show work-related pulmonary function changes and dose-effect relationships with dust exposure. Br J Ind Med 1982; 39:330-37
5. doPico GA, Reddan W, Flaherty D, et al. Respiratory abnormalities among grain handlers. Am Rev Respir Dis 1977; 115:915-27
6. McDuffie HH, Pahwa P, Dosman JA. Respiratory health status of 3,098 Canadian grain workers studied longitudinally. Am J Ind Med 1991; 20:753-62
7. Huy T, de Schipper K, Chan-Yeung M, et al. Grain dust and lung function dose-response relationships. Am Rev Respir Dis 1991; 144:1314-21
8. Dosman JA, Cotton DJ, Graham BL, et al. Chronic bronchitis and decreased forced expiratory flow rates in lifetime non-smoking grain workers. Am Rev Respir Dis 1980; 121:11-16
9. James AL, Cookson WOCM, Buters G, et al. Symptoms and longitudinal changes in lung function in young seasonal grain handlers. Br J Ind Med 1986; 43:587-91
10. Chan-Yeung M, Schulzer M, Maclean L, et al. Follow-up study of the grain elevator workers in the Port of Vanconver. Arch Environ Health 1981; 36:75-81
11. Tabona M, Chan-Yeung M, Enarson D, et al. Host factors affecting longitudinal decline in lung spirometry among grain elevator workers. Chest 1984; 85:782-86
12. Clapp WD, Thorne PS, Frees KL, et al. The effects of inhalation of grain dust extract and endotoxin on upper and lower airways. Chest 1993; 104:825-30
13. Jagielo PJ, Thorne PS, Watt JL, et al. Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects. Chest 1996; 110:263-70
14. Olenchock SA, Lewis DM, Mull JC. Composition of extracts of airborne grain dusts: lectins and lymphocyte mitogens. Environ Health Perspect 1986; 66:119-23
15. Schwartz DA, Thorne PS, Yahla S, et al. The role of endotoxin in grain dust-induced lung disease. Am J Respir Crit Care Med 1995; 152:603-08
16. Donham K, Haglind P, Peterson Y, et al. Environmental and health studies of farm workers in Swedish were confinement buildings. Br J Ind Med 1989; 46:31-37
17. Thelin A, Tegler O, Rylander R. Lung reactions during poultry handling related to dust and bacterial endotoxin levels. Eur J Respir Dis 1984; 65:266-71
18. Kennedy SM, Christiani DC, Eisen EA, et al. Cotton dust and endotoxin exposure-response relationships in cotton textile workers. Am Rev Respir Dis 1987; 135:194-200
19. Castellan RM, Olenchock SA, Hankinson JL, et al. Acute bronchoconstruction induced by cotton dust: dose-related responses to endotoxin and other dust factors. Ann Intern Med 1984; 101:157-63
20. Rylander R, Haglind P, Lundholm M. Endotoxin in cotton dust and respiratory function decrement among cotton workers in an experimental cardroom. Am Rev Respir Dis 1985; 131:209-13
21. Clapp WD, Thorne PS, Frees KL, et al. The effects of inhalation of grain dust extract and endotoxin on upper and lower airways. Chest 1993; 104:825-30
22. Clapp WD, Becker S, Quay J, et al. Grain dust-induced airflow obstruction and inflammation of the lower respiratory tract. J Respir Crit Care Med 1994; 150:611-17
23. Jagielo PJ, Frees KL, Watt JL, et al. Inhaled grain dust and endotoxin produce similar biologic and physiologic responses [abstract]. Clin Res 1994; 42:190A
24. Jagielo PJ, Thorne PS, Kern JA, et al. Role of endotoxin in grain dust-induced lung inflammation in mice. Am J Physiol (Lung Cell Mol Physiol) 1996; 270:L1052-59
25. Schwartz DA, Thorne PS, Jagielo PJ, et al. Endotoxin responsiveness and grain dust-induced inflammation in the lower respiratory tract. Am J Physiol 1994; 267:L609-17
26. Schwartz DA. Grain dust, endotoxin, and airflow obstruction. Chest 1996; 109:57S-63S
27. Jagielo PJ, Quinn TJ, Qureshi N, et al. Grain dust-induced lung inflammation is reduced by Rhodobacter sphaeroides diphosphoryl lipid A. Am J Physiol (in press)
28. Barnes PJ. Mechanisms of action of glucocorticoids in asthma. Am Respir Crit Care Med 1996; 154:S21-27
29. Paliogianni F, Raptis A, Ahuja SS, et al. Negative transcriptional regulation of human interleukin-2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J Clin Invest 1993; 91:1481-89
30. Yi ES, Remick DG, Lim Y, et al. The intratracheal administration of endotoxin: X. Dexamethasone downregulates neutrophil emigration and cytokine expression in vivo. Inflammation 1996; 20:165-75
31. Schmidt LE, Thorne PS, Watt JL, et al. Is an abbreviated bronchial challenge with histamine valid? Chest 1992; 101: 141-45
32. Deetz DC, Jagielo PJ, Quinn TJ, et al. The kinetics of grain dust-induced inflammation of the lower respiratory tract. Am J Respir Crit Care Med 1997; 155:254-59
33. American Thoracic Society. Snowbird workshop on standardization of spirometry. Am Rev Respir Dis 1979; 119:831-38
34. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 1985; 132:180-82
35. O'Leary EC, Marder P, Zuckerman SH. Glucocorticoid effects in an endotoxin-induced rat pulmoonary inflammation model: differential effects on neutrophil influx, integrin expression, and inflammatory mediators. Am J Respir Cell Mol Biol 1996; 15:97-106
36. O'Leary EC, Zuckerman SH. Glucocorticoid-mediated inhibition of neutrophil emigration in an endotoxin-induced rat pulmonary inflammation model occurs without an effect on airway MIP-2 levels. Am J Respir Cell Mol Biol 1997; 16:267-74
37. Ziegler EJ, McCutchan JA, Fierer J, et al. Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 1982; 307: 1225-30
38. Baumgartner JD, Glauser MP, McCutchan JA, et al. Prevention of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. Lancet 1985; 2:59-63
39. Ziegler EJ, Teng NNH, Douglas H, et al. Treatment of Pseudomonas bacteremia in neutropenic rabbits with human monoclonal IgM antibody against E. coli lipid A [abstract]. Clin Res 1987; 35:619A
40. Calandra T, Glanser MP, Shellekens J, et al. Treatment of Gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective double-blind randomized trial. J Infect Dis 1988; 155:312-19
41. Greenman RL, Schein RMN, Martin MA. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative sepsis. JAMA 1991; 266:1097-1102
42. Wenzel RP, Bone RC, Fein AM. Results of a second double-blind randomized, controlled trial of anti-endotoxin antibody E5 in Gram-negative sepsis. Programs and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, 1991
43. Ziegler EJ, Fisher CJ, Sprung CL, et al. Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: a randomized, double-blind, placebo-controlled trial. N Engl J Med 1991; 324:429-36
44. Bone RC, Balk RA, Fein AM, et al. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. Crit Care Med 1995; 23:994-1006
45. Battafarano RJ, Dahlberg PS, Ratz CA, et al. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro. Surgery 1995; 118:318-24
46. Marra MN, Wilde CG, Collins MS, et al. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 1992; 148:532-37
47. Elsbach P. Bactericidal permeability-increasing protein in host defence against Gram-negative bacteria and endotoxin. Antimicrobial peptides (Ciba Foundation Symposium) 1994; 186:176-89
48. Gazzano-Santoro H, Parent JB, Grinna L, et al. High-affinity binding of the bactericidal/permeability increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun 1992; 60:4754-61
49. Marra MN, Thornton MB, Snable JL, et al. Endotoxin-binding and nentralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5. Crit Care Med 1994; 22:559-65
50. von der Mohlen MAM, Kimmings AN, Wedel NI, et al. Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/ permeability-increasing protein. J Infect Dis 1995; 172: 144-51